Skip to main content
. 2017 Feb 24;14(3):276–288. doi: 10.1177/1479972316687208

Table 3.

Quality appraisal of included studies.

Study (Year) Intervention Systematic reviews Primary studies
R-AMSTAR score Participants Summarya RCTs (n) Low-risk of biasc Meta-analysis quality Summaryb
Education/action plans
 Effing et al. 12 e Self-management education with or without action plans 34 2239 High/High 13 3 High High/High
 Tan et al. 13 Self-management education 33 2103 High/High 12 2 High High/High
 Turnock et al.14 d Action plans 39 367 High/Low 3 0 High High/High
 Walters et al.15 d Action plans – COPD exacerbations 34 574 High/Low 5 1 High High/High
Complex interventions with an SM focus
 Bentsen et al.16 Range of SM interventions 26 529 Low/Low 4 NR NA NA
 Dickens et al.17 Range of complex interventions 35 3941 High/High 32 8 Medium High/Med.
 Harrison et al.18 Range of SM – following COPD exacerbation 30 1115 Low/High 7 NR NA NA
 Kruis et al.19 Range of IDM interventions 37 2997 High/High 26 5 High High/High
 Zwerink et al.20e Range of SM interventions 39 3688 High/High 29 9 High High/High
 Jordan et al.21 Range of SM – following exacerbation 40 1502 High/High 10 1 High High/High
Pulmonary rehabilitation
 McCarthy et al.22 Pulmonary rehabilitation 41 3822 High/High 65 17 High High/High
Telehealth
 Cruz et al.23 Home telemonitoring 33 587 High/Low 9 2 High High/High
 Kamei et al.24 Telehome monitoring-based telenursing 30 550 Low/Low 9 6 Medium Low/Med.
 Lundell et al.25 Telehealth – making pulmonary rehabilitation accessible 36 982 High/Low 9 2 Low High/Low
 McLean et al.26 Telehealth 39 1004 High/High 10 0 High High/High
Outreach nursing programmes
 Wong et al.27 Home care by outreach nursing 37 1498 High/High 9 4 High High/High

R-AMSTAR: Revised Assessment of Multiple Systematic Reviews; COPD: chronic obstructive pulmonary disease; IDM: integrated disease management; RCTs: randomized controlled trials; SM: self-management; NR: not reported; NA: not applicable.

aSummary includes R-AMSTAR score/number of participants. Papers judged to be of higher quality if scored ≥31 and lower quality if scored <31. Reviews judged to be of lower impact if total participant numbers are fewer than 1000.

bSummary includes risk of bias/meta-analysis quality score. If >50% of the included RCTs were at high risk of bias, review is rated as high risk of bias. The meta-analysis quality was evaluated using Higgins et al.’s quality assessment tool and results categorized into high-, medium- and low-quality meta-analysis.

cNumber of the total primary studies identified as being at low risk of bias.

dWalter’s Cochrane review (CR) is an update of Turnock’s CR.

eZwerink’s CR is an update of Effing’s CR. Note: In Zwerink’s update, they chose to exclude studies with education as the only active intervention.